Oui, vivre dans des zones où des infections virales sont fréquentes augmente le risque.
EnvironnementInfections viralesRisque
#5
Les voyages à l'étranger augmentent-ils le risque ?
Oui, voyager dans des régions où des épidémies d'infections virales sont présentes peut augmenter le risque.
VoyagesÉpidémiesRisque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome uvéo-méningo-encéphalique : Questions médicales les plus fréquentes",
"headline": "Syndrome uvéo-méningo-encéphalique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome uvéo-méningo-encéphalique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-18",
"dateModified": "2025-03-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome uvéo-méningo-encéphalique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies auto-immunes du système nerveux",
"url": "https://questionsmedicales.fr/mesh/D020274",
"about": {
"@type": "MedicalCondition",
"name": "Maladies auto-immunes du système nerveux",
"code": {
"@type": "MedicalCode",
"code": "D020274",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111.258"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome uvéo-méningo-encéphalique",
"alternateName": "Uveomeningoencephalitic Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D014607",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Leen Alblaihed",
"url": "https://questionsmedicales.fr/author/Leen%20Alblaihed",
"affiliation": {
"@type": "Organization",
"name": "Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, 6th Floor, Suite 200, Baltimore, MD 21201, USA. Electronic address: https://twitter.com/LeenAlblaihed."
}
},
{
"@type": "Person",
"name": "Maite Anna Huis In 't Veld",
"url": "https://questionsmedicales.fr/author/Maite%20Anna%20Huis%20In%20%27t%20Veld",
"affiliation": {
"@type": "Organization",
"name": "Department of Emergency Medicine, Elisabeth TweeSteden Ziekenhuis, Hilvarenbeekseweg 60, 5022 GC Tilburg, the Netherlands; Department of Emergency Medicine, University of Maryland School of Medicine, MD, USA. Electronic address: m.huisintveld@etz.nl."
}
},
{
"@type": "Person",
"name": "Yehuda Shoenfeld",
"url": "https://questionsmedicales.fr/author/Yehuda%20Shoenfeld",
"affiliation": {
"@type": "Organization",
"name": "Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer 5265601, Ramat-Gan; Reichmann University, Herzliya, Israel."
}
},
{
"@type": "Person",
"name": "Rosanna Fulchiero",
"url": "https://questionsmedicales.fr/author/Rosanna%20Fulchiero",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Inova Children's Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA."
}
},
{
"@type": "Person",
"name": "Patricia Seo-Mayer",
"url": "https://questionsmedicales.fr/author/Patricia%20Seo-Mayer",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Inova Children's Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA; Division of Nephrology and Hypertension, Pediatric Specialists of Virginia, 3023 Hamaker Court, Suite 600, Fairfax, VA 22031, USA; Virginia Commonwealth School of Medicine, Richmond, VA, USA. Electronic address: Pseo-mayer@psvcare.org."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Paranoid thinking and perceived competitive intention.",
"datePublished": "2023-03-10",
"url": "https://questionsmedicales.fr/article/36923500",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.15003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rethinking paranoid ideation and reasoning: A pilot study based on the argumentative theory of reasoning.",
"datePublished": "2023-05-27",
"url": "https://questionsmedicales.fr/article/37307645",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbtep.2023.101884"
}
},
{
"@type": "ScholarlyArticle",
"name": "Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia spectrum disorders: a randomized clinical trial.",
"datePublished": "2022-08-15",
"url": "https://questionsmedicales.fr/article/35971137",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-022-06614-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Experimental studies of paranoid thinking in clinical and nonclinical populations: a systematic review and meta-analysis.",
"datePublished": "2023-07-10",
"url": "https://questionsmedicales.fr/article/37427557",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/S0033291723001708"
}
},
{
"@type": "ScholarlyArticle",
"name": "A randomised controlled test in virtual reality of the effects on paranoid thoughts of virtual humans' facial animation and expression.",
"datePublished": "2024-07-24",
"url": "https://questionsmedicales.fr/article/39048648",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-67534-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies auto-immunes du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D020274"
},
{
"@type": "ListItem",
"position": 5,
"name": "Syndrome uvéo-méningo-encéphalique",
"item": "https://questionsmedicales.fr/mesh/D014607"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome uvéo-méningo-encéphalique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome uvéo-méningo-encéphalique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome uvéo-méningo-encéphalique",
"description": "Comment diagnostiquer le syndrome uvéo-méningo-encéphalique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent ce syndrome ?\nLe syndrome peut-il être confondu avec d'autres maladies ?\nQuelle est l'importance de l'analyse du LCR ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Paranoid+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome uvéo-méningo-encéphalique",
"description": "Quels sont les symptômes principaux du syndrome ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on avoir de la fièvre avec ce syndrome ?\nLes symptômes sont-ils toujours présents ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Paranoid+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome uvéo-méningo-encéphalique",
"description": "Comment prévenir le syndrome uvéo-méningo-encéphalique ?\nLes vaccinations sont-elles efficaces ?\nQuelles mesures d'hygiène sont recommandées ?\nY a-t-il des groupes à risque ?\nLes voyages augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Paranoid+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome uvéo-méningo-encéphalique",
"description": "Quel est le traitement principal du syndrome ?\nLes antibiotiques sont-ils nécessaires ?\nComment gérer les symptômes neurologiques ?\nY a-t-il des traitements préventifs ?\nQuelle est la durée du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Paranoid+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome uvéo-méningo-encéphalique",
"description": "Quelles sont les complications possibles ?\nLe syndrome peut-il entraîner des séquelles à long terme ?\nY a-t-il un risque de récidive ?\nComment surveiller les complications ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Paranoid+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome uvéo-méningo-encéphalique",
"description": "Quels sont les facteurs de risque connus ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nL'environnement peut-il affecter le risque ?\nLes voyages à l'étranger augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Paranoid+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer le syndrome uvéo-méningo-encéphalique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, l'imagerie cérébrale et des analyses de liquide céphalorachidien."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des IRM, des tomodensitométries et des analyses de sang et de LCR sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent ce syndrome ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des maux de tête, des troubles visuels et des convulsions peuvent indiquer le syndrome."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il être confondu avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec d'autres infections neurologiques comme la méningite bactérienne."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'analyse du LCR ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse du LCR permet de détecter des signes d'inflammation et d'infection, cruciaux pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux du syndrome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des troubles de la vision, et des signes neurologiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des convulsions, des troubles de la conscience et des déficits neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de la gravité de l'infection."
}
},
{
"@type": "Question",
"name": "Peut-on avoir de la fièvre avec ce syndrome ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fièvre est un symptôme fréquent, souvent accompagnée de signes d'inflammation."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains patients peuvent présenter des symptômes légers ou intermittents."
}
},
{
"@type": "Question",
"name": "Comment prévenir le syndrome uvéo-méningo-encéphalique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par la vaccination contre les infections virales et l'hygiène personnelle."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent réduire le risque d'infections virales associées au syndrome."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter le contact avec des personnes malades sont recommandés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des groupes à risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées et celles vivant dans des zones d'épidémie sont à risque accru."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones où des infections virales sont endémiques peut augmenter le risque."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal inclut des antiviraux, des corticostéroïdes et des soins de soutien."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques ne sont pas efficaces contre les infections virales, mais peuvent être utilisés si une infection bactérienne est suspectée."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes neurologiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes neurologiques peuvent être gérés par des anticonvulsivants et des soins neurologiques spécialisés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de traitements préventifs spécifiques pour ce syndrome."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie selon la gravité de l'infection et la réponse au traitement, souvent plusieurs semaines."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des séquelles neurologiques, des troubles de la vision et des crises épileptiques."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il entraîner des séquelles à long terme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent développer des séquelles neurologiques à long terme après le traitement."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de récidive ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de récidive dépend de la cause sous-jacente et de l'état immunitaire du patient."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier avec des examens neurologiques et des imageries est essentiel pour surveiller les complications."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce et approprié de l'infection."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, les infections virales antérieures et l'exposition à des vecteurs."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont souvent plus à risque de développer ce syndrome."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'infections neurologiques augmentent le risque de développer ce syndrome."
}
},
{
"@type": "Question",
"name": "L'environnement peut-il affecter le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre dans des zones où des infections virales sont fréquentes augmente le risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions où des épidémies d'infections virales sont présentes peut augmenter le risque."
}
}
]
}
]
}
Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, 6th Floor, Suite 200, Baltimore, MD 21201, USA. Electronic address: https://twitter.com/LeenAlblaihed.
Publications dans "Syndrome uvéo-méningo-encéphalique" :
Department of Emergency Medicine, Elisabeth TweeSteden Ziekenhuis, Hilvarenbeekseweg 60, 5022 GC Tilburg, the Netherlands; Department of Emergency Medicine, University of Maryland School of Medicine, MD, USA. Electronic address: m.huisintveld@etz.nl.
Publications dans "Syndrome uvéo-méningo-encéphalique" :
Department of Pediatrics, Inova Children's Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA; Division of Nephrology and Hypertension, Pediatric Specialists of Virginia, 3023 Hamaker Court, Suite 600, Fairfax, VA 22031, USA; Virginia Commonwealth School of Medicine, Richmond, VA, USA. Electronic address: Pseo-mayer@psvcare.org.
Publications dans "Syndrome uvéo-méningo-encéphalique" :
Paranoid thinking, that others are hostile, can be seen even in the general population. Paranoia is considered the expectation that others are competitors who aim to maximize the differences in payoff...
Cognitive theories assume an imbalance of intuitive and analytical reasoning in paranoid ideation. The argumentative theory of reasoning offers an approach on the primary function of reasoning and its...
327 participants completed the Social Network Index (SNI), the Paranoia Checklist (PCL), and the Cognitive Reflection Test-2 (CRT2). Moreover, preference and frequency of discussions were assessed. In...
The discussion group showed lower distorted reflective reasoning than the control group. Discussion preference and/or frequency was associated with frequency and disturbance of paranoid thoughts, as w...
Due to the online format environmental factors could not be held constant and no intrasubject comparison of the CRT2 could be computed in the trial. Furthermore, the sample mainly consisted of psychol...
The results contribute to the understanding of distorted reflective reasoning and provides preliminary evidence that the argumentative theory of reasoning may offer a promising perspective for delusio...
Schizophrenia spectrum disorders cause suffering for patients, relatives, and the surrounding society. Paranoid ideations, encompassing ideas of social reference and manifest persecutory delusions, ar...
This study is a randomized, assessor-blinded parallel-groups multi-center superiority clinical trial, fulfilling the CONSORT criteria for non-pharmacological treatment. A total of 256 patients diagnos...
The trial will elucidate whether VR-CBT can enhance therapy efficacy for paranoid ideations. Additionally, Trial findings will provide evidence on the effectiveness and cost-effectiveness of VR-CBT fo...
ClinicalTrials.gov NCT04902066 . Initial release April 9th, 2021....
Paranoia is common in clinical and nonclinical populations, consistent with continuum models of psychosis. A number of experimental studies have been conducted that attempt to induce, manipulate or me...
Virtual reality (VR) is increasingly used in the study and treatment of paranoia. This is based on the finding that people who mistakenly perceive hostile intent from other people also perceive simila...
Psychotic experiences have been associated with distortions in affective functioning, including aberrancies in affect dynamics. However, it remains unclear whether the two principal symptom dimensions...
Persecutory ideas are highly frequent in psychotic disorders and particularly in schizophrenia. Although several measures exist to assess persecutory ideas in both clinical and non-clinical samples, t...
100 individuals with schizophrenia and 72 non-clinical controls were recruited. We used the GPTS-8, a brief 8-item version of the R-GPTS recently developed and validated in the French general populati...
Confirmatory factor analysis supported the original two-factor structure (social reference and persecution subscales) of the GPTS-8. The GPTS-8 was positively and moderately correlated with the Positi...
The French GPTS 8-item brief scale-8 retains the psychometric strengths of the R-GPTS in schizophrenia with relevant clinical validity. The GPTS-8 can consequently be used as a short and quick measure...
Paranoia is a common and impairing psychosis symptom, which exists along a severity continuum that extends into the general population. Individuals at clinical high-risk for psychosis (CHR) frequently...
Participants were CHR individuals (n = 103), mixed clinical controls (n = 80), and healthy controls (n = 71) who completed self-report and interview measures. Confirmatory factor analysis (CFA), psych...
CFA replicated a two-factor structure for the RGPTS and the associated reference and persecution scales were reliable. CHR individuals scored significantly higher on both reference and persecution, re...
These results demonstrate the reliability and validity of the RGPTS, though its scales related more weakly to severity in CHR individuals. The RGPTS may be useful in future work aiming to develop symp...
Paranoia is the belief that others intend you harm. It is related to conspiracy theories, wherein those others represent an organized faction, coordinating the harm against self and others, and violat...
Cognitive Bias Modification for paranoia (CBM-pa) is a novel, theory-driven psychological intervention targeting the biased interpretation of emotional ambiguity associated with paranoia. Study object...
In a double-blind randomised controlled trial, sixty-three outpatients with clinically significant paranoia were randomised to either CBM-pa or an active control (text reading) between April 2016 and ...
A total of 122 patients were screened and 63 were randomised. The recruitment rate was 51.2%, with few dropouts (four out of 63) and follow-up rates were 90.5% (1-month) and 93.7% (3-months). Each ses...
CBM-pa is feasible for patients with paranoia. A fully powered randomised control trial is warranted....